Valuation: Abbott Laboratories

Market Cap 184B 165B 152B 137B 257B 17,449B 261B 1,803B 725B 9,176B 690B 675B 28,947B P/E 2026 *
35.1x
P/E 2027 * 25.6x
Enterprise Value 207B 186B 171B 155B 290B 19,685B 295B 2,035B 818B 10,352B 778B 761B 32,657B EV / Sales 2026 *
4.15x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.44%
Yield 2027 * 2.6%
1 day+3.51%
1 week+4.42%
Current month+8.26%
1 month+8.26%
3 months+0.85%
6 months+14.56%
Current year-11.94%
1 week 11.4
Extreme 11.4
11.8
1 month 10.6
Extreme 10.6
11.8
Current year 9.2
Extreme 9.2
14.8
1 year 9.2
Extreme 9.2
14.8
3 years 9.2
Extreme 9.2
16
5 years 9.2
Extreme 9.2
16
10 years 9.2
Extreme 9.2
16
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
+3.51%+4.42% - - 184B
+1.56%+2.41%-14.82%+14.19% 184B
-6.38%-4.98%-20.90%+11.15% 112B
-0.59%+1.18%+6.12%+37.97% 118B
+3.42%+1.71%-42.32%+9.52% 94.58B
+0.09%-0.05%-3.04%+78.44% 63.13B
-0.46%+0.42%+8.19%+82.97% 55.66B
-0.23%-0.52%+10.31%-21.19% 53.9B
-4.30%-1.64%-12.30%+39.06% 43.42B
+0.58%+2.00%-1.07%-6.43% 34.68B
Average -0.28%+0.06%-7.76%+27.30% 84.36B
Weighted average by Cap. +0.29%+0.23%-10.66%+25.22%

Financials

2026 *2027 *
Net sales 49.96B 44.78B 41.22B 37.31B 69.81B 4,744B 71.07B 490B 197B 2,495B 187B 183B 7,870B 53.53B 47.98B 44.16B 39.97B 74.79B 5,082B 76.14B 525B 211B 2,673B 201B 197B 8,432B
Net income 5.64B 5.06B 4.66B 4.21B 7.89B 536B 8.03B 55.38B 22.25B 282B 21.18B 20.73B 889B 7.66B 6.87B 6.32B 5.72B 10.71B 728B 10.9B 75.2B 30.22B 383B 28.76B 28.14B 1,207B
Net Debt 23.55B 21.11B 19.43B 17.59B 32.91B 2,237B 33.51B 231B 92.88B 1,176B 88.39B 86.51B 3,710B 20.14B 18.05B 16.61B 15.04B 28.14B 1,912B 28.65B 198B 79.41B 1,006B 75.57B 73.96B 3,172B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
26-10-30 €11.80 +3.51%
26-10-29 €11.40 -1.72%
26-10-28 €11.60 -.--%
26-10-27 €11.60 +1.75%
26-10-26 €11.40 +0.88%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
106.20USD
Average target price
118.52USD
Spread / Average Target
+11.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories